AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 96 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | 0.0% | 1,930 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -66.7% | 1,930 | +411.9% | 0.00% | – |
Q3 2020 | $3,000 | 0.0% | 377 | +3.9% | 0.00% | – |
Q2 2020 | $3,000 | -25.0% | 363 | -28.8% | 0.00% | – |
Q4 2018 | $4,000 | -66.7% | 510 | -60.9% | 0.00% | – |
Q3 2018 | $12,000 | -25.0% | 1,304 | -14.4% | 0.00% | – |
Q2 2018 | $16,000 | +100.0% | 1,523 | +96.0% | 0.00% | – |
Q1 2018 | $8,000 | +700.0% | 777 | +203.5% | 0.00% | – |
Q2 2017 | $1,000 | – | 256 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |